Zynerba Pharmaceuticals

Zynerba Pharmaceuticals is dedicated to developing next-generation transdermal cannabinoid therapies for patients with rare neuropsychiatric disorders by manufacturing drugs and enhancing the permeation of transdermal cannabinoid candidates to modulate pathways in the central nervous system.